Menora Mivtachim Valuation Multiples

Discover Menora Mivtachim's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Medibank, Vienna Insurance Group, Affiliated Managers Group, Primerica and more.

Menora Mivtachim Overview

About Menora Mivtachim

Menora Mivtachim Holdings Ltd is a diversified insurance and finance group that operates in Israel. The company specializes in asset management and diversified insurance services, including general, life, and health insurance. Menora is also active within the capital market in a variety of fields, including corporate finance, investment banking, structured finance, and more. The company offers a broad variety of mutual funds that invest in various avenues in Israel and around the world, while also managing pension products and provident funds. The company's operating segments include Life insurance and long-term savings, focusing on policies, pension, and provident funds for death and disability risks, the Health insurance segment, and the Property and casualty insurance segment.


Founded

1935

HQ

Israel

Employees

3.7K

Financials (FY)

Revenue: $3.8B
Net Income: $785M

EV

$10B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Menora Mivtachim Financials

Menora Mivtachim reported last fiscal year revenue of $3.8B.

In the same fiscal year, Menora Mivtachim generated $785M in net income.


Menora Mivtachim P&L

In the most recent fiscal year, Menora Mivtachim reported revenue of $3.8B and net income of $785M.

Menora Mivtachim is profitable as of last fiscal year, with net margin of 21%.

See analyst estimates for Menora Mivtachim
Last FY202320242025202620272028
Revenue$3.8B$4.2B$4.9B$3.8B
Net Profit$785M$172M$360M$785M
Net Margin21%4%7%21%

Financial data powered by Morningstar, Inc.

Menora Mivtachim Stock Performance

Menora Mivtachim has current market cap of $9.6B, and enterprise value of $10B.

Market Cap Evolution


Menora Mivtachim's stock price is $153.50.

Menora Mivtachim share price increased by 2.6% in the last 30 days, and by 60.6% in the last year.

Menora Mivtachim has an EPS (earnings per share) of $12.56.

See more trading valuation data for Menora Mivtachim
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$10B$9.6B-3.5%2.6%-5.2%60.6%$12.56

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Menora Mivtachim Valuation Multiples

Menora Mivtachim trades at 2.7x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Menora Mivtachim

Menora Mivtachim Financial Valuation Multiples

As of July 8, 2026, Menora Mivtachim has market cap of $9.6B and EV of $10B.

Menora Mivtachim has a P/E ratio of 12.2x.

Last FY202320242025202620272028
EV/Revenue2.7x2.4x2.1x2.7x
P/E12.2x55.9x26.6x12.2x
EV/FCF15.5x(52.9x)22.5x15.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Menora Mivtachim Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Menora Mivtachim Margins & Growth Rates

In the most recent fiscal year, Menora Mivtachim reported net margin of 21%.

See estimated margins and future growth rates for Menora Mivtachim

Menora Mivtachim Margins

Last FY20242025202720282029
Net Margin21%7%21%
FCF Margin17%9%17%

Menora Mivtachim Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth18%(23%)
Net Profit Growth110%118%
FCF Growth(336%)45%

Data powered by FactSet, Inc. and Morningstar, Inc.

Menora Mivtachim Operational KPIs

Menora Mivtachim's revenue per employee in the last FY averaged $1.0M.

Access forward-looking KPIs for Menora Mivtachim
Last FY20232024202620272028
Revenue per Employee$1.0M--
S&M Expenses to Revenue-3%2%
G&A Expenses to Revenue-3%3%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Menora Mivtachim Competitors

Menora Mivtachim competitors include Medibank, Vienna Insurance Group, Affiliated Managers Group, Primerica, Oscar Health, ICICI Lombard General, Sofina, Korea Investment Holdings, Everbright Securities and Polar Capital Technology Trust.

Most Menora Mivtachim public comparables operate across Insurance Carriers and Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Medibank1.6x1.5x19.4x16.3x
Vienna Insurance Group0.5x0.6x--
Affiliated Managers Group5.8x5.4x8.1x10.0x
Primerica3.2x3.1x--
Oscar Health0.4x0.3x(17.9x)50.8x
ICICI Lombard General2.8x2.8x41.8x41.0x
Sofina51.9x---
Korea Investment Holdings13.2x13.8x--

This data is available for Pro users. Sign up to see all Menora Mivtachim competitors and their valuation data.

Start Free Trial

Investments by Menora Mivtachim

Menora Mivtachim has invested in 19 companies to date.

Latest investment by Menora Mivtachim was on January 29th 2025. Menora Mivtachim invested in UVeye in their $41M Series D round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Menora Mivtachim

UVeye
Pershing Square Holdings
Tally
Travelier
Description
UVeye is a Hod Hasharon-headquartered computer vision company developing AI-powered underbody and exterior vehicle inspection systems. Deployed at over 200 sites worldwide including car dealerships and fleets, the technology detects issues like oil leaks, tire damage, rust, and exhaust faults in seconds. Partnerships with Volvo Cars and General Motors support national dealer installations since 2022.
Pershing Square Holdings Ltd is a closed-ended investment scheme. The company's investment objective is to preserve capital and to seek maximum, long-term capital appreciation commensurate with reasonable risk. It seeks to achieve its investment objective through long and occasionally short positions in equity or debt securities of public U.S. and non-U.S. issuers, derivative instruments, and other financial instruments.
Tally is a financial automation platform founded in 2015 that manages credit card debt through automated payments. San Francisco-based, it negotiates lower interest rates with issuers like Chase and Citi while optimizing payoff strategies. The app monitors spending and builds savings accounts for users tackling over $10 billion in debt.
Travelier is a travel technology firm that operates digital marketplaces for booking buses, ferries, trains, and other ground transport in Southeast Asia, Latin America, and Europe. Its subsidiaries include Bookaway.com for intercity buses and ferries, 12Go.asia for multi-modal tickets in Thailand and Vietnam, Getbybus in Croatia, Plataforma10 in Portugal, and SeatOS for fleet management software. Launched in 2017 as Bookaway Group, the Tel Aviv-headquartered company connects local operators with international tourists through real-time availability and mobile payments.
HQ CountryUnited StatesUnited KingdomUnited StatesIsrael
HQ City
Teaneck, NJ
-
San Francisco, CA
Tel Aviv
Deal Date29 Jan 20253 Jun 20243 Oct 202210 May 2022
RoundSeries DSecondarySeries DSeries C
Raised$41M$1.1B$80M$35M
InvestorsW. R. Berkley; More Provident Funds; MyBerg; UMC Capital; Menora Mivtachim; Woven CapitalICONIQ Capital; Consulta; Menora Mivtachim; Arch Capital Group; Banco BTG PactualKleiner Perkins; Menora Mivtachim; Flucas Ventures; Andreessen Horowitz; Shasta Ventures; Cowboy Ventures; Sway VenturesAleph; Menora Mivtachim; Tenere Capital; Entrée Capital; Corner Ventures; Red Dot Capital Partners
Valuationundisclosed$11B$855Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Menora Mivtachim investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Menora Mivtachim

When was Menora Mivtachim founded?Menora Mivtachim was founded in 1935.
Where is Menora Mivtachim headquartered?Menora Mivtachim is headquartered in Israel.
How many employees does Menora Mivtachim have?As of today, Menora Mivtachim has over 3K employees.
Is Menora Mivtachim publicly listed?Yes, Menora Mivtachim is a public company listed on Tel Aviv Stock Exchange.
What is the stock symbol of Menora Mivtachim?Menora Mivtachim trades under MMHD ticker.
When did Menora Mivtachim go public?Menora Mivtachim went public in 2002.
Who are competitors of Menora Mivtachim?Menora Mivtachim main competitors include Medibank, Vienna Insurance Group, Affiliated Managers Group, Primerica, Oscar Health, ICICI Lombard General, Sofina, Korea Investment Holdings, Everbright Securities, Polar Capital Technology Trust.
What is the current market cap of Menora Mivtachim?Menora Mivtachim's current market cap is $9.6B.
What is the current revenue of Menora Mivtachim?Menora Mivtachim's last fiscal year revenue is $3.8B.
What is the current EV/Revenue multiple of Menora Mivtachim?Current revenue multiple of Menora Mivtachim is 2.7x.
Is Menora Mivtachim profitable?No, Menora Mivtachim is not profitable.
How many companies Menora Mivtachim has acquired to date?Menora Mivtachim hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Menora Mivtachim has invested to date?As of July 2026, Menora Mivtachim has invested in 19 companies.
What was the last Menora Mivtachim investment?On 29th January 2025 Menora Mivtachim invested in UVeye, participating in a $41M Series D round, alongside W. R. Berkley, More Provident Funds, MyBerg, UMC Capital, and Woven Capital.

See public comps similar to Menora Mivtachim

Lists including Menora Mivtachim

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial